CEO: Scott Drake
Headquarters: Cleveland, Ohio
Investment Date: July 2015
APO Financing: $29,400,000
Trading Venue: NASDAQ GM (VRAY)
ViewRay was founded on the belief that enhanced real-time visualization combined with on-line adapting and accurate dose recording will significantly improve the safety and efficacy of radiation therapy, leading to better outcomes for patients.
MRI-guided radiation therapy was conceived by company founder James F. Dempsey, PhD, while he was a member of the radiation oncology faculty at the University of Florida in 2004. And ViewRay holds the exclusive worldwide license for its combination of MRI and radiation therapy technologies.